Sponsors (7)
The bill increases athlete participation rights and federal transparency/accountability around U.S. WADA funding, but risks reducing U.S. influence, diverting anti-doping resources to the Treasury, and creating administrative delays that could harm anti-doping programs.
Independent and other U.S. athletes gain clearer definitions and explicit protections to serve on international anti-doping governance bodies and participate in WADA selection processes, increasing their ability to influence anti-doping policy decisions that affect them.
U.S. representation and oversight (via ONDCP) over WADA could improve governance and transparency of anti-doping decisions, potentially making outcomes fairer for U.S. athletes and strengthening accountability of international anti-doping bodies.
Taxpayers and Congress get increased visibility into U.S. WADA spending because ONDCP must provide spending plans at least 30 days before obligating funds, improving federal transparency and fiscal accountability for those dues.
U.S. withholding of up to the full WADA dues could reduce U.S. influence inside WADA, weakening the country's ability to shape anti-doping operations and potentially interrupting programs that benefit clean athletes.
Any returned but unobligated WADA dues that must be deposited into the Treasury general fund at fiscal year end could divert money away from anti-doping activities unless alternative funding is provided, threatening testing and program continuity.
ONDCP's required annual determinations and additional reporting/approval steps create extra administrative workload that could delay dues payments or other program actions, slowing implementation of anti-doping support.
Based on analysis of 2 sections of legislative text.
Gives ONDCP annual oversight of WADA, requires governance and athlete‑selection tests, mandates reports, and allows withholding of U.S. dues if standards are unmet.
Introduced January 23, 2025 by Marsha Blackburn · Last progress January 23, 2025
Creates a new statutory oversight role for the Office of National Drug Control Policy (ONDCP) over the World Anti‑Doping Agency (WADA). It updates a federal statute to add new definitions, requires ONDCP to make timely determinations about WADA’s governance and athlete representation, directs ONDCP to report to Congress on barriers to U.S. participation, and authorizes ONDCP to withhold U.S. membership dues to WADA if WADA fails to meet specified governance and selection standards.